Biomedical Engineering Reference
In-Depth Information
164. Hamdy S, Elamanchili P, Alshamsan A et al (2007) Enhanced antigen-specific primary CD4+
and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand
monophosphoryl lipid A in poly(D, L-lactic-co-glycolic acid) nanoparticles. J Biomed
Mater Res A 81:652-662
165. Solbrig CM, Saucier-Sawyer JK, Cody V et al (2007) Polymer nanoparticles for immuno-
therapy from encapsulated tumor-associated antigens and whole tumor cells. Mol Pharm
4:47-57
166. Wendorf J, Chesko J, Kazzaz J et al (2008) A comparison of anionic nanoparticles and
microparticles as vaccine delivery systems. Hum Vaccin 4:44-49
167. Nayak B, Panda AK, Ray P et al (2009) Formulation, characterization and evaluation of
rotavirus encapsulated PLA and PLGA particles for oral vaccination. J Microencapsul
26:154-165
168. Hamdy S, Molavi O, Ma Z et al (2008) Co-delivery of cancer-associated antigen and Toll-like
receptor 4 ligand in PLGA nanoparticles induces potent CD8
+
T cell-mediated anti-tumor
immunity. Vaccine 26:5046-5057
169. Caputo A, Sparnacci K, Ensoli B et al (2008) Functional polymeric nano/microparticles for
surface adsorption and delivery of protein and DNA vaccines. Curr Drug Deliv 5:230-242
170. Slutter B, Plapied L, Fievez V et al (2009) Mechanistic study of the adjuvant effect of
biodegradable nanoparticles in mucosal vaccination. J Control Release 138:113-121
171. Gutierro I, Hern´ndez RM, Igartua M et al (2002) Size dependent immune response after
subcutaneous, oral and intranasal administration of BSA loaded nanospheres. Vaccine
21:67-77
172. Chong CS, Cao M, Wong WW et al (2005) Enhancement of T helper type 1 immune
responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery.
J Control Release 102:85-99
173. Reddy ST, Rehor A, Schmoekel HG (2006) In vivo targeting of dendritic cells in lymph nodes
with poly(propylene sulfide) nanoparticles. J Control Release 112:26-34
174. Reddy ST, Van Der Vlies AJ, Simeoni E et al (2007) Exploiting lymphatic transport and
complement activation in nanoparticle vaccines. Nat Biotechnol 25:1159-1164
175. Fifis T, Gamvrellis A, Crimeen-Irwin B et al (2004) Size-dependent immunogenicity:
therapeutic and protective properties of nano-vaccines against
tumors.
J
Immunol
173:3148-3154
